Advanced Ca-doped MOF nanocarriers for Co-delivery of Doxorubicin/pCRISPR DOI Creative Commons
Bahareh Farasati Far, Mohammad Reza Naimi‐Jamal, Sepideh Ahmadi

и другие.

Nano Materials Science, Год журнала: 2024, Номер unknown

Опубликована: Июль 1, 2024

Cancer treatment often requires a multimodal approach, such as combining chemotherapy and gene therapy. However, challenges low therapeutic efficacy off-target effects hinder the effectiveness of these treatments. In this study, use calcium-doped metal-organic frameworks Cu2(BDC)2(DABCO) nanocarrier platform for co-delivery doxorubicin (DOX) plasmid CRISPR (pCRISPR) proposed to enhance anticancer efficiency. We demonstrated that Ca-doped MOF nanocarriers significantly improved uptake DOX pCRISPR by in cancer cells. The with resulted significant rise cell death decreased targeted expression.

Язык: Английский

Charcoal Nanoparticles as a Delivery System for Doxorubicin and Sorafenib in Treatment of Hepatocellular Carcinoma DOI Open Access

Aisha Elgurashi Abdulla,

Toga Khalid Mohamed Gader,

Marvit Osman Widdatallah Omer

и другие.

Advances in Nanoparticles, Год журнала: 2024, Номер 13(03), С. 45 - 60

Опубликована: Янв. 1, 2024

Background: Hepatocellular carcinoma (HCC) is the most common type of liver cancer and one leading causes cancer-related death worldwide. Advanced HCC displays strong resistance to chemotherapy, traditional chemotherapy drugs do not achieve satisfactory therapeutic efficacy. The delivery compounds target site a major challenge in treatment many diseases. Objective: This study aims evaluate activated charcoal nanoparticles as drug system for anticancer agents (Sorafenib Doxorubicin) Cancer Stem Cells. Method: percent efficiency entrapment (% EE) doxorubicin sorafenib entrapped onto was obtained by determining free concentration supernatant-prepared solutions. Then characterizations were formed determination particle size distribution, zeta potential, polydispersity index (PDI). activity Charcoal, Doxorubicin-ACNP, sorafenib-ACNP, doxorubicin, solutions measured based on cell viability percentage HepG2 lines (ATCC-CCL 75). In vitro RBC's toxicity Doxorubicin/sorafenib loaded estimated hemolysis percentage. Results: synthesized Doxorubicin-ACNP Sorafenib-ACNP evaluated their physiochemical properties also examined. Essentially, Efficiency Entrapment (EE %) found be 87.5% 82.66% Sorafenib-ACNP, respectively. loading capacity 34.78% 24.31% Sorafenib-ACNP. Using Dynamic Light scattering [DLS] hydrodynamic surface narrow sample distribution (18, 68, 190 nm charcoal, 105, 255, 712 91, 295, 955 sorafenib), A charge −13.2, −15.6 −17 doxorubicin/charcoal, sorafenib/charcoal nanoparticles. cytotoxic in-vitro against it observed that Drug ACNP improved when compared Doxorubicin or Sorafenib alone. Moreover, testing potential DOX-ACNP showed significant reduction red blood cells Conclusion: conclusion, notable state this regarded first investigate use Activated further arena hepatocellular carcinoma. noteworthy along with reduced RBCs rendering an efficacious carrier low potential.

Язык: Английский

Процитировано

1

Fabrication of polymeric sorafenib coated chitosan and fucoidan nanoparticles: Investigation of anticancer activity and apoptosis in colorectal cancer cells DOI Creative Commons

Yu Zhou,

Jin Liu, Sai Ma

и другие.

Heliyon, Год журнала: 2024, Номер 10(14), С. e34316 - e34316

Опубликована: Июль 1, 2024

The most prevalent form of colon cancer also ranks high among cancer-related deaths globally. Traditional chemotherapy drugs do not provide sufficient therapeutic efficacy, and advanced demonstrates considerable resistance to chemotherapy. As an oral kinase inhibitor, sorafenib (SOR) suppresses the growth tumour cells, formation new blood vessels, death cells. Unfortunately, sorafenib's limited bioavailability, rapid metabolism, poor solubility have severely its clinical use. We developed nanoparticles targeting P-selectin SOR, with fucoidan (FU) as a ligand. SOR-CS-FU-NPs were by coating polylactide-

Язык: Английский

Процитировано

1

A tumor Microenvironment-triggered protein-binding Near-infrared-II Theranostic nanoplatform for Mild-Temperature photothermal therapy DOI

Wenlong Huang,

Bo Jin,

Huili Gong

и другие.

Journal of Colloid and Interface Science, Год журнала: 2024, Номер 680, С. 375 - 388

Опубликована: Ноя. 9, 2024

Язык: Английский

Процитировано

1

Antimicrobial Properties of Metal-Organic Frameworks DOI
Bahareh Farasati Far

ACS symposium series, Год журнала: 2024, Номер unknown, С. 147 - 180

Опубликована: Март 5, 2024

Exploring novel antimicrobial agents has become increasingly imperative in the face of escalating resistance. Metal-organic frameworks (MOFs), a class crystalline materials renowned for their remarkable porosity and versatile functionalities, have emerged as promising candidates combating microbial infections. This chapter offers comprehensive overview properties MOFs, shedding light on synthesis, mechanisms action, potential applications diverse fields. Commencing with discussion global challenges resistance, this underscores urgency innovative approaches research. The unique attributes including tunable structures ability to encapsulate bioactive molecules are examined context designing effective agents. rational design strategies employed enhance activity MOFs elucidated, encompassing incorporation metal nodes, functionalization organic ligands, synergistic combination conventional antibiotics. underpinning action explored, aspects such membrane disruption, reactive oxygen species generation, targeted intracellular delivery. need standardized testing methodologies, in-depth toxicity assessments, thorough understanding MOF-microbe interactions is emphasized chapter. integration computational translation laboratory findings practical identified pivotal steps harnessing full fight against As healthcare community seeks address pressing issue stand at forefront, poised contribute transformative solutions pursuit interventions.

Язык: Английский

Процитировано

0

Advanced Ca-doped MOF nanocarriers for Co-delivery of Doxorubicin/pCRISPR DOI Creative Commons
Bahareh Farasati Far, Mohammad Reza Naimi‐Jamal, Sepideh Ahmadi

и другие.

Nano Materials Science, Год журнала: 2024, Номер unknown

Опубликована: Июль 1, 2024

Cancer treatment often requires a multimodal approach, such as combining chemotherapy and gene therapy. However, challenges low therapeutic efficacy off-target effects hinder the effectiveness of these treatments. In this study, use calcium-doped metal-organic frameworks Cu2(BDC)2(DABCO) nanocarrier platform for co-delivery doxorubicin (DOX) plasmid CRISPR (pCRISPR) proposed to enhance anticancer efficiency. We demonstrated that Ca-doped MOF nanocarriers significantly improved uptake DOX pCRISPR by in cancer cells. The with resulted significant rise cell death decreased targeted expression.

Язык: Английский

Процитировано

0